05/21/2024 9:12 AM | BML Investment Partners, L.P. (Filed by) Reneo Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/16/2024 7:56 AM | Leonard Braden Michael (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/16/2024 7:58 AM | Leonard Braden Michael (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 8:14 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 8:38 AM | Reneo Pharmaceuticals (Subject)
| Form 425 | |
04/26/2024 5:16 AM | Reneo Pharmaceuticals (Filer)
| Form 10-K/A | |
03/28/2024 3:05 PM | Reneo Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/28/2024 3:00 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:01 PM | Reneo Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/05/2024 3:01 PM | Octagon Capital Advisors LP (Filed by) Reneo Pharmaceuticals (Subject)
| Form SC 13G | |
12/26/2023 4:00 PM | Reneo Pharmaceuticals (Subject) TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D | |
12/15/2023 3:55 PM | Novo Holdings A/S (Filed by) Reneo Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/14/2023 8:26 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
11/13/2023 3:58 PM | Reneo Pharmaceuticals (Filer)
| Form 424B5 | |
11/13/2023 4:08 PM | Reneo Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/30/2023 3:47 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 5:08 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 4:04 PM | Hall Ashley (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2023 4:33 PM | Hall Ashley (Reporting) Reneo Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023 4:16 PM | GREY MICHAEL G (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:10 PM | Novo Holdings A/S (Reporting) Reneo Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023 6:15 PM | Novo Holdings A/S (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
06/08/2023 7:09 PM | Mathers Edward T (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:02 PM | Dube Eric M (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:06 PM | Reneo Pharmaceuticals (Issuer) Seltzer Stacey Denenberg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:13 PM | O'Donnell Niall (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:14 PM | Muralidhar Bali (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:15 PM | Hoelscher Paul W. (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:16 PM | GREY MICHAEL G (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:17 PM | Blunt Roshawn A. (Reporting) Reneo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |